This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Academia Sinica. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Innovations in ALS Research: The Contributions of Lien-Szu Wu.
Introduction: Lien-Szu Wu is an esteemed inventor based in Tainan, Taiwan, recognized for his significant contributions to medical research, particularly in the field of amyotrophic lateral sclerosis (ALS). With a focus on developing innovative models for understanding diseases, Wu's work is pivotal in exploring therapeutic options for ALS.
Latest Patents: Lien-Szu Wu holds a patent titled "Non-human animal model for amyotrophic lateral sclerosis (ALS) with loss-of-TDP-43 function." This groundbreaking invention involves a rodent model that exhibits ALS-like symptoms due to the loss of function of TAR-DNA binding protein-43 (TDP-43) in its spinal cord motor neurons. This model is instrumental in identifying potential agents for treating, preventing, or inhibiting ALS linked to TDP-43 dysfunction.
Career Highlights: Wu is affiliated with Academia Sinica, one of Taiwan's leading research institutions, where he engages in pioneering research aimed at combating neurodegenerative diseases. His innovative approaches have garnered attention within the academic community and beyond, positioning him as a notable figure in ALS research.
Collaborations: Throughout his career, Lien-Szu Wu has collaborated with other talented researchers, including Che-Kun James Shen. Together, they contribute to advancing the understanding of ALS and exploring new therapeutic avenues.
Conclusion: Lien-Szu Wu's innovative work and dedicated research efforts in developing non-human animal models for ALS underscore the importance of scientific inquiry in addressing complex neurological disorders. His contributions not only advance our understanding of ALS but also pave the way for future therapeutic developments to improve the lives of those affected by this devastating condition.